These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 9183794)
1. Development and characterization of nifedipine lipospheres. Vyas SP; Singh R; Dimitrijevic D Pharmazie; 1997 May; 52(5):403-4. PubMed ID: 9183794 [No Abstract] [Full Text] [Related]
2. Nifedipine preparations on the Belgian market: a comparative study. De Braekeleer K; Fierens C; Corthout J J Pharm Belg; 2009 Dec; (4):141-6. PubMed ID: 20183991 [TBL] [Abstract][Full Text] [Related]
3. Development of nifedipine-loaded coated gelatin microcapsule as a long acting oral delivery. Li DX; Kim JO; Oh DH; Lee WS; Hong MJ; Kang JY; Choi JS; Woo JS; Yong CS; Choi HG Arch Pharm Res; 2009 Jan; 32(1):127-32. PubMed ID: 19183885 [TBL] [Abstract][Full Text] [Related]
4. Assessment of bioavailability of experimental controlled release microcapsules of nifedipine. Mallick S; Gupta BK; Ghosal SK Acta Pol Pharm; 2000; 57(3):175-80. PubMed ID: 11143705 [TBL] [Abstract][Full Text] [Related]
5. Development of novel sustained-release system, disintegration-controlled matrix tablet (DCMT) with solid dispersion granules of nilvadipine (II): in vivo evaluation. Tanaka N; Imai K; Okimoto K; Ueda S; Tokunaga Y; Ibuki R; Higaki K; Kimura T J Control Release; 2006 May; 112(1):51-6. PubMed ID: 16545477 [TBL] [Abstract][Full Text] [Related]
6. Deciphering nifedipine in vivo delivery from modified release dosage forms: Identification of food effect. Ilić M; Kovačević I; Parojčić J Acta Pharm; 2015 Dec; 65(4):427-41. PubMed ID: 26677899 [TBL] [Abstract][Full Text] [Related]
7. Comparison of two marketed nifedipine modified-release formulations: an exploratory clinical food interaction study. Wonnemann M; Schug B; Anschütz M; Brendel E; De Nucci G; Blume H Clin Ther; 2008 Jan; 30(1):48-58. PubMed ID: 18343242 [TBL] [Abstract][Full Text] [Related]
8. Physical properties and dissolution behaviour of nifedipine/mannitol solid dispersions prepared by hot melt method. Zajc N; Obreza A; Bele M; Srcic S Int J Pharm; 2005 Mar; 291(1-2):51-8. PubMed ID: 15707731 [TBL] [Abstract][Full Text] [Related]
9. Nifedipine in ischemic heart disease. Kloner RA Circulation; 1995 Sep; 92(5):1074-8. PubMed ID: 7648647 [No Abstract] [Full Text] [Related]
10. Determination of nifedipine in human plasma and its use in bioequivalence study. Guo Y; Dai J; Qian G; Guo N; Ma Z; Guo X Int J Pharm; 2007 Aug; 341(1-2):91-6. PubMed ID: 17507190 [TBL] [Abstract][Full Text] [Related]
11. [Treatment with nifedipine retard: increasing doses as a therapeutic method]. Lobos Berajano JM; Lahoz Rallo F; Seguido Aliaga P; Castellanos Maroto J; Robles Pérez R Rev Clin Esp; 1989 Jan; 184(1):47-9. PubMed ID: 2704870 [No Abstract] [Full Text] [Related]
12. Synthesis and characterization of novel poly(sebacic anhydride-co-Pluronic F68/F127) biopolymeric microspheres for the controlled release of nifedipine. Shelke NB; Aminabhavi TM Int J Pharm; 2007 Dec; 345(1-2):51-8. PubMed ID: 17616283 [TBL] [Abstract][Full Text] [Related]
13. Critical questions concerning the validity of the Bayer study report of "Differences in bioavailability between 60 mg of nifedipine osmotic push-pull systems after fasted and fed administration". Meyer MC Int J Clin Pharmacol Ther; 2010 Jun; 48(6):405-11; author reply 412-5, 416-8. PubMed ID: 20497749 [No Abstract] [Full Text] [Related]
15. Withdrawal of nifedipine capsules: jeopardising the treatment of acute severe hypertension in pregnancy? Langton PE Med J Aust; 1998 Jan; 168(1):43-4. PubMed ID: 9451398 [No Abstract] [Full Text] [Related]
16. Controlled release of nifedipine from mucoadhesive tablets of its inclusion complexes with beta-cyclodextrin. Chowdary KP; Kamalakara RG Pharmazie; 2003 Oct; 58(10):721-4. PubMed ID: 14609284 [TBL] [Abstract][Full Text] [Related]